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Wolf’s	 isotopic	 response	designates	 the	appearance	of	a	new	der-
matosis	at	the	site	of	an	already	healed	unrelated	skin	disease.1 The 
initial	dermatosis	is	usually	a	herpetic	infection,	in	particular	herpes	









ported to the clinic. The patient had undergone several chemother-
apy	 cycles	 –	 including	 rituximab,	 cyclophosphamide,	 fludarabine	
and	alemtuzumab	–	without	achieving	complete	clinical	remission.	
Three	 years	 after	 the	 diagnosis,	while	 on	 cyclophosphamide	 and	
prednisolone,	the	patient	developed	a	sudden	widespread	non-pru-
ritic papulo-vesiculous dermatosis. Histopathological examination 
revealed	 intraepidermal	vesicles	with	a	mixed	 inflammatory	 infil-
trate	 and	 solitary	 keratinocytes	within	 the	 blisters	 (Figure	 1).	We	





A	 few	days	 after	 the	 herpetic	 lesions	 had	 healed,	 the	 pa-
tient developed a monomorphic erythemato-violaceous papular 
eruption	 on	 the	 scars	 of	 the	 previous	 herpetic	 lesions	 (Figure	 2).	
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FIgure 1: 
A. Widespread papulo-vesiculous 
eruption; B. Grouped	 confluent	 vesi-
cles and bullae
FIgure 2: 
A. Widespread erythemato-violaceus 
papular dermatosis; B. Multiple mo-






cleared under high-dose systemic corticotherapy and the patient re-
mained stable without cutaneous recurrence or evidence of blastic 
transformation at a 24-month follow-up. 
DISCUSSION
The	 skin	 is	 an	 active	 immune	 organ.	 Several	 immune-mediated	
reactions	 following	 different	 stimuli	 have	 been	 reported,	 such	 as	
the	well-known	Koebner	isomorphic	response.2	On	the	other	hand,	
Wolf’s	 isotopic	 response	designates	 the	appearance	of	 two	 subse-










have been published in the last two decades. Information on fol-
low-up	and	prognosis	was	reported	for	eight	patients,	of	which	six	
experienced	resolution	of	cutaneous	lesions,	and	the	clinical	prog-
nosis did not appear to worsen.4,6,7		On	the	other	hand,	two	patients	
had a poor outcome: one of them died of B-CLL after 24 months4 
and	the	other	patient	–	whose	disease	had	been	in	remission	for	3	
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Figure 3: A. Superficial and deep dermal infiltrate (x40, H&E); 




cal staining for CD5, 
CD20 and CD43 ne-
gative for CD3 (He-
matoxylin - eosin, 
x40)
years before the varicella episode – experienced medullar involve-
ment with poor response to combined chemotherapy, requiring al-
logenic bone marrow transplant.5
In our case, an already existing neoplastic proliferation arose de novo 
on the skin after a herpetic infection. The reported cutaneous leuke-
mic infiltration had no effect on the disease course during follow-up 
time. Our results corroborate the previous observations of a better 
prognosis in patients with B-cell cutaneous leukemic infiltration fol-
lowing a herpetic infection perhaps because they reflect a cutaneous 
reactivity pattern to a stimulus rather than a true metastatic pro-
cess.4,7 These observations should be kept in mind when selecting 
therapeutic approach in such cases.q
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